Home › Nasopharyngeal Carcinoma › Missouri
Nasopharyngeal Carcinoma clinical trials in Missouri
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in Missouri.
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06029270A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Children's Mercy Hospitals and Clinics, Kansas City
- Washington University School of Medicine, St Louis
RecruitingPhase 2
Up to age 21 · All sexes · Updated Sep 14, 2026 · NCT06064097Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Saint Francis Medical Center, Cape Girardeau
- Lake Regional Hospital, Osage Beach
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.